# Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus

> **NCT00133107** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 4 (actual)

## Conditions studied

- Lichen Planus, Oral

## Interventions

- **DRUG:** efalizumab

## Key facts

- **NCT ID:** NCT00133107
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2011-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133107, "Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00133107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*